Main subject:
NPS [2]

This publication presents the data and findings of the risk assessment on N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide (cyclopropylfentanyl), carried out by the extended Scientific Committee of the EMCDDA on 21 March 2018. On the basis of the Risk Assessment Report — and on the initiative of the European Commission — on 27 September 2018, the Council decided that cyclopropylfentanyl should be subject to control measures across the Member States.
NPS [2]
NPS [3]

Links
[1] http://www.emcdda.europa.eu/system/files/publications/9607/Risk%20assessment%20cyclopropylfentanyl.pdf
[2] http://www.emcdda.europa.eu/publications-database?f[0]=field_search_topic:1315
[3] http://www.emcdda.europa.eu/publications-database?f[0]=field_keywords:1287
[4] http://www.emcdda.europa.eu/publications/risk-assessments/methoxyacetylfentanyl
[5] http://www.emcdda.europa.eu/news/2018/6/council-implementing-decision-to-control-cyclopropylfentanyl-and-methoxyacetylfentanyl_en